The effect of additional antimicrobial therapy on the outcomes of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis.
Ching-Yi ChenChao-Hsien ChenCheng-Yi WangChih-Cheng LaiChien-Ming ChaoYu-Feng WeiPublished in: Respiratory research (2021)
In patients with IPF, adding antimicrobial therapy to usual care did not improve mortality or lung function decline but increased gastrointestinal toxicity.
Keyphrases
- idiopathic pulmonary fibrosis
- lung function
- staphylococcus aureus
- cystic fibrosis
- chronic obstructive pulmonary disease
- air pollution
- interstitial lung disease
- healthcare
- palliative care
- metabolic syndrome
- risk factors
- cardiovascular disease
- systemic sclerosis
- mesenchymal stem cells
- insulin resistance
- weight loss
- chronic pain
- smoking cessation